# Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/adjuvant-pembrolizumab-versus-placebo-in-resected-stage-iii-melanoma-eortc-1325/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Alexander Eggermont,Christian U. Blank,Mario Mandalà,Georgina V Long,Victoria Atkinson,Stéphane Dalle,Andrew Haydon,Andrey Meshcheryakov,Adnan Khattak,Matteo S. Carlino,Shahneen Sandhu,James Larkin,Susana Puig,Paolo A. Ascierto,Piotr Rutkowski,Dirk Schadendorf,Rutger H.T. Koornstra,Leonel F. Hernandez‐Aya,Anna Maria Di Giacomo,Alfons J.M. van den Eertwegh,Jean‐Jacques Grob,Ralf Gutzmer,Rahima Jamal,Paul Lorigan,Alexander C. J. van Akkooi,Clemens Krepler,Nageatte Ibrahim,Sandrine Marréaud,Michal Kiciński,Stefan Suciu,Caroline Robert,Alex Menzies,Thierry Lesimple,Michele Maio,Gerald P. Linette,Michael P. Brown,Peter Hersey,Inge Marie Svane,Laurent Mortier,Jacob Schachter,Catherine Barrow,Ragini R. Kudchadkar,Xinni Song,Caroline Dutriaux,Pietro Quaglino,Friedegund Meier,Paola Queirolo,Daniil Stroyakovskiy,Lars Bastholt,B. Guillot,Claus Garbe,Pablo L. Ortiz‐Romero,Florent Grange,Peter Mohr,Alain P. Algazi,Oliver Bechter,Micaela Hernberg,Jean‐Philippe Arnault,Philippe Saïag,Carmen Loquai,Frank Meiß,Jan‐Christoph Simon,Gil Bar‐Sela,Vanna Chiarion‐Sileni,Bernard M. Fitzharris,Mike McCrystal,Phillip Parente,Jean‐François Baurain,P. Combemale,Célèste Lebbé,Axel Hauschild,Naoya Yamazaki,Reinhard Dummer,Mohammed Milhem,Marcin Dzienis,John Walker,L. Geoffrois,M.‐T. Leccia,Lutz Kretschmer,Daniel Hendler,Michal Lotem,Andrzej Maćkiewicz,Lidija Kandolf Sekulović,Elaine Dunwoodie,Christoph Höeller,L. Machet,Jessica C. Hassel,Geke A.P. Hospers,Maria-Jose Passos,Max Levin,Martin Fehr,Philippa Corrie,Ashita Waterston,Sigrun Hallmeyer,Henrik Schmidt,V. Descamps,J.‐P. Lacour,Carola Berking,Felix Kiecker,Pier Francesco Ferrucci |
| Citations | 392 |
| DOI | 10.1016/s1470-2045(21)00065-6 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | http://hdl.handle.net/10072/416580 |
| OpenAlex ID | https://openalex.org/W3153228158 |
| PMID | 33857412 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Jean‐François Baurain](https://scholariq.org/researchers/jean-francois-baurain/)
- [Shahneen Sandhu](https://scholariq.org/researchers/shahneen-sandhu/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [Cutaneous Melanoma Detection and Management](https://scholariq.org/topics/cutaneous-melanoma-detection-and-management/)

## Paper topics

- [Cutaneous Melanoma Detection and Management](https://scholariq.org/topics/cutaneous-melanoma-detection-and-management/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.